Page 144 - THE EVOLUTION OF EARLY ARTHRITIS AND CARDIOVASCULAR RISK Samina A. Turk

CHAPTER 7
Figure 1. Comparison of improvement in patient-reported and clinical outcomes after 12 weeks of treatment, in patients in physician-perceived remission, who were in and not in patient-perceived remission
Table 3. Differences in baseline values of patients in physician-perceived remission, stratified into patients in and not in self-perceived remission after 12 weeks of treatment
In physician-perceived remission, n=55
DAS44
VAS global (mm) TJC44ritchie
SJC44ritchie
ESR (mm/hour)
CRP (mg/l)
RAID pain
RAID FDA
RAID fatigue
RAID sleep
RAID physical well-being RAID emotional well-being RAID coping
HAQ
In patient-perceived remission, n=36
3.0 (1.1)
47.5 [28.3-72.0] 4.0 [3.0-9.0]
6.0 [2.3-12.0] 14.5 [8.0-31.0] 10.7 [4.2-24.8] 7.0 [3.0-8.0] 6.0 [2.0-7.0] 5.0 [1.0-8.0] 6.0 [2.0-8.0] 3.0 [1.0-6.0] 3.0 [1.0-7.0] 3.0 [1.0-8.0] 0.6 [0.1-1.1]
Not in patient-perceived remission, n=19
3.2 (1.0)
66.0 [50.0-76.0]
6.0 [4.0-11.0] 6.0 [3.0-12.0] 20.0 [12.0-40.0] 7.2 [3.9-32.0] 7.0 [4.8-8.0] 5.0 [4.0-8.0] 6.0 [3.0-8.0] 5.5 [2.0-7.3] 3.5 [3.0-6.8] 4.0 [2.5-7.0] 5.0 [2.5-8.0] 0.8 [0.4-1.5]
Numbers are presented as mean (SD) or median [IQR] where appropriate.
CRP: C-reactive protein, DAS44: disease activity score of 44 joints, ESR: erythrocyte sedimentation rate, FDA: functional disability assessment, HAQ: Health Assessment Questionnaire, IQR: interquartile range, l: liter, mg: milligram, mm: millimeter, n:number,
142